Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?

Amarin (AMRN) shares soared 12.5% in the last trading session to close at $18.84. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 11.4% gain over the past four weeks.The price surge can be attributed to growing investor confidence regarding the company’s sole marketed drug, Vascepa, which is approved as an adjunct to diet for treating severe hypertriglyceridemia or elevated triglyceride levels.This biopharmaceutical company is ex ...